Mark Genovese

Back to Profile

Publication Details

  • A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.

    van Vollenhoven RF, Park JL, Genovese MC, West JP, McGuire JL. Lupus. 1999; 8 (3): 181-7

    To determine if dehydroepiandrosterone (DHEA) is beneficial in severe systemic lupus erythematosus (SLE).

    PubMedID: 10342710

Stanford Medicine Resources:

Footer Links: